© 2025 MJH Life Sciences™ and Patient Care Online. All rights reserved.
AIDS Reader
Articles
When to Start Antiretroviral Therapy? NA-ACCORD Stimulates the Debate
February 27, 2009
One of the most highly discussed and publicized HIV-related presentations at the recent Interscience Conference on Antimicrobial Agents and Chemotherapy/Infectious Diseases Society of America (ICAAC/IDSA)
Antiretroviral Therapy Update From the 48th ICAAC/46th IDSA Annual Meeting
February 05, 2009
The combined 48th Interscience Conference on Antimicrobial Agents and Chemotherapy/46th Infectious Diseases Society of America Annual Meeting (ICAAC/IDSA) was held in Washington, DC, from October 24 to 28, 2008.
Many People Disregard Advice to Get HIV Tests, Epidemic of Cancers Feared With HIV Link
February 05, 2009
Many clinicians are not screening patients for HIV as a routine part of health care because they perceive testing takes too much time and because many insurers are reluctant to reimburse for the procedure.
Fatal HIV-Associated Anaplastic Large-Cell Lymphoma
February 05, 2009
Lymphoma is a well-known complication of HIV infection. Such AIDS-defining lymphomas are usually aggressive B-cell lymphomas. However, epidemiological data have also linked HIV infection with an increased risk of T-cell lymphoma.
Two Memos: Issues and Reminders
February 04, 2009
Every think tank and every policy wonk in the country is working on white papers, analyses, proposals, critiques, and plans in the hope that their ideas will be placed before the new president and the new Congress.
Start Anti-HIV Treatment Early, in Adults and Infants
January 02, 2009
Debate over the optimal time to initiate antiretroviral therapy for HIV infection is as old as the availability of effective anti-HIV treatment.1 As I've noted in several past editorials, there were cogent arguments on both sides,
AIDS Treatment Should Start Sooner, Gilead AIDS Pill Effective in Study With Weekends Off, AIDS Vaccine Poised for Human Tests
December 02, 2008
A new study presented at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy in Washington, DC, suggests that persons infected with HIV should begin antiretroviral treatment sooner than guidelines currently recommend (Marchione M. Associated Press. October 26, 2008). The large study finds that delaying antiretroviral therapy until patients’ T-cell counts fall below 350/µL nearly doubles the risk of death in the next few years of their lives when compared with the risk of death in patients whose treatment was started earlier.
Preventing Sexually Transmitted Infections, 2008
December 02, 2008
In September 2008, data from what is purported to be the largest sexual health survey ever conducted in the United States, cataloging more than 1.2 million Internet responses to an “anonymous” questionnaire, were released.1 There were the expected admissions from respondents concerning frequent use of behavioral disinhibitors-alcohol being the most popular-to manage anxiety and “have an excuse” to do what they wanted to do anyway, ie, have sex:
Decrease in the Proportion of Injection Drug Use–Related HIV/AIDS in Massachusetts, New York, Connecticut, and Rhode Island
December 02, 2008
Injection drug use (IDU) has been a route for HIV transmission since the beginning of the epidemic.
Editorial Comment: We’re Doing Something Right!
December 02, 2008
As discussed by Mitty and colleagues,1 the proportion of HIV infections associated with injection drug use (IDU) has dropped dramatically across the United States, including the northeastern portion of the country.